Safety, pharmacokinetics and efficacy of E6011, an anti-fractalkine monoclonal antibody, in a first-in-patient phase 1/2 study in rheumatoid arthritis

Category Primary study
JournalAnnals of the Rheumatic Diseases
Year 2016
This article has no abstract
Epistemonikos ID: 559f3a45195bccbd9a389b88e2315b13c4af331c
First added on: Feb 07, 2025